Skip to content

Nasdaq · CIK 0001285550

CLPT ClearPoint Neuro, Inc.

Insider trading from SEC Form 4. Last filing 10 d ago. Close $10.48 on Oct 9, 2026, +21% from the 52-week low and -64% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company

Price and insider trades, last year

CLPTOct 9, 2026 · close 10.48

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at ClearPoint Neuro, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
46ModerateTimothy T. Richards
director
sell
$133k
10,000 shares
-11%+26% from low-30% from high
54ModerateJoseph Burnett
CEO and President
sell
$282k
21,247 shares
-8%+27% from low-30% from high
46ModerateLynnette C Fallon
director
sell
$128k
10,200 shares
-20%+20% from low-33% from high

Transactions

The last 79 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026Timothy T. Richards
director
AGrant or award
Common Stock
+319$12.21$3,89587,86310 d ago
Oct 1, 2026R John Fletcher
director
AGrant or award
Common Stock
+993$12.21$12k132,00410 d ago
Sep 2, 2026Joseph Burnett
CEO and President
MOption exercise
Common Stock
+12,517$3.47$43k130,72039 d ago
Sep 2, 2026Joseph Burnett
CEO and President
MOption exercise
Stock Options (right to buy)derivative
-12,517$0.00$061,88739 d ago
Jun 10, 2025Joseph Burnett
CEO and President
FTax withholding
Common Stock
-15,476$13.29$206k9,887Jun 12, 2025
Jun 10, 2025L. Jeremy Stigall
Chief Business Officer
FTax withholding
Common Stock
-3,561$13.29$47k70,747Jun 12, 2025
Jun 10, 2025Danilo D'Alessandro
Chief Financial Officer
FTax withholding
Common Stock
-4,754$13.29$63k65,992Jun 12, 2025
Jun 10, 2025Timothy T. Richards
director
SOpen-market sale
Common Stock
-10,000$13.28$133k77,381Jun 12, 2025
Jun 9, 2025Joseph Burnett
CEO and President
SOpen-market sale
Common Stockindirect: See Footnote
-21,247$13.29$282k243,522Jun 11, 2025
Jun 3, 2025Lynnette C Fallon
director
SOpen-market sale
Common Stock
-9,000$12.53$113k42,101Jun 5, 2025
Jun 3, 2025Lynnette C Fallon
director
SOpen-market sale
Common Stock
-1,200$12.88$15k40,901Jun 5, 2025
May 22, 2025B Kristine Johnson
director
AGrant or award
Restricted Stock Unitsderivative
+12,417$0.00$012,417May 23, 2025
May 22, 2025Lynnette C Fallon
director
AGrant or award
Restricted Stock Unitsderivative
+12,417$0.00$012,417May 23, 2025
May 22, 2025R John Fletcher
director
AGrant or award
Restricted Stock Unitsderivative
+12,417$0.00$012,417May 23, 2025
May 22, 2025Pascal E R Girin
director
AGrant or award
Restricted Stock Unitsderivative
+12,417$0.00$012,417May 23, 2025
May 22, 2025Matthew B. Klein
director
AGrant or award
Restricted Stock Unitsderivative
+12,417$0.00$012,417May 23, 2025
May 22, 2025Linda M. Liau
director
AGrant or award
Restricted Stock Unitsderivative
+12,417$0.00$012,417May 23, 2025
May 22, 2025Timothy T. Richards
director
AGrant or award
Restricted Stock Unitsderivative
+12,417$0.00$012,417May 23, 2025
May 16, 2025Timothy T. Richards
director
MOption exercise
Common Stock
+21,093--87,381May 19, 2025
May 16, 2025Linda M. Liau
director
MOption exercise
Common Stock
+21,093--52,384May 19, 2025
May 16, 2025Matthew B. Klein
director
MOption exercise
Common Stock
+21,093--50,518May 19, 2025
May 16, 2025Pascal E R Girin
director
MOption exercise
Common Stock
+21,093--96,111May 19, 2025
May 16, 2025B Kristine Johnson
director
MOption exercise
Common Stock
+21,093--58,699May 19, 2025
May 16, 2025Lynnette C Fallon
director
MOption exercise
Common Stock
+21,093--51,101May 19, 2025
May 16, 2025R John Fletcher
director
MOption exercise
Common Stock
+21,093--115,491May 19, 2025
May 16, 2025Linda M. Liau
director
MOption exercise
Restricted Stock Unitsderivative
-21,093--0May 19, 2025
May 16, 2025Pascal E R Girin
director
MOption exercise
Restricted Stock Unitsderivative
-21,093--0May 19, 2025
May 16, 2025R John Fletcher
director
MOption exercise
Restricted Stock Unitsderivative
-21,093--0May 19, 2025
May 16, 2025Lynnette C Fallon
director
MOption exercise
Restricted Stock Unitsderivative
-21,093--0May 19, 2025
May 16, 2025B Kristine Johnson
director
MOption exercise
Restricted Stock Unitsderivative
-21,093--0May 19, 2025
May 16, 2025Matthew B. Klein
director
MOption exercise
Restricted Stock Unitsderivative
-21,093--0May 19, 2025
May 16, 2025Timothy T. Richards
director
MOption exercise
Restricted Stock Unitsderivative
-21,093--0May 19, 2025
Apr 1, 2025Pascal E R Girin
director
AGrant or award
Common Stock
+525$11.89$6,24275,018Apr 2, 2025
Apr 1, 2025Timothy T. Richards
director
AGrant or award
Common Stock
+938$11.89$11k66,288Apr 2, 2025
Apr 1, 2025R John Fletcher
director
AGrant or award
Common Stock
+486$11.89$5,77994,398Apr 2, 2025
Mar 12, 2025Joseph Burnett
CEO and President
MOption exercise
Common Stock
+42,414--313,537Mar 14, 2025
Mar 12, 2025Mazin Sabra
Chief Operating Officer
MOption exercise
Common Stock
+13,050--57,830Mar 14, 2025
Mar 12, 2025Danilo D'Alessandro
Chief Financial Officer
MOption exercise
Common Stock
+16,313--79,030Mar 14, 2025
Mar 12, 2025L. Jeremy Stigall
Chief Business Officer
MOption exercise
Common Stock
+15,497--79,853Mar 14, 2025
Mar 12, 2025Danilo D'Alessandro
Chief Financial Officer
FTax withholding
Common Stock
-8,284$13.18$109k70,746Mar 14, 2025
Mar 12, 2025Mazin Sabra
Chief Operating Officer
FTax withholding
Common Stock
-6,627$13.18$87k51,203Mar 14, 2025
Mar 12, 2025L. Jeremy Stigall
Chief Business Officer
FTax withholding
Common Stock
-5,545$13.18$73k74,308Mar 14, 2025
Mar 12, 2025Joseph Burnett
CEO and President
FTax withholding
Common Stock
-23,405$13.18$308k290,132Mar 14, 2025
Mar 12, 2025L. Jeremy Stigall
Chief Business Officer
MOption exercise
Restricted Stock Unitsderivative
-15,497--61,990Mar 14, 2025
Mar 12, 2025Joseph Burnett
CEO and President
MOption exercise
Restricted Stock Unitsderivative
-42,414--169,657Mar 14, 2025
Mar 12, 2025Mazin Sabra
Chief Operating Officer
MOption exercise
Restricted Stock Unitsderivative
-13,050--52,202Mar 14, 2025
Mar 12, 2025Danilo D'Alessandro
Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-16,313--65,253Mar 14, 2025
Mar 11, 2025L. Jeremy Stigall
Chief Business Officer
MOption exercise
Common Stock
+8,292--67,323Mar 13, 2025
Mar 11, 2025Danilo D'Alessandro
Chief Financial Officer
MOption exercise
Common Stock
+4,146--64,823Mar 13, 2025
Mar 11, 2025Danilo D'Alessandro
Chief Financial Officer
FTax withholding
Common Stock
-2,106$12.70$27k62,717Mar 13, 2025
Mar 11, 2025L. Jeremy Stigall
Chief Business Officer
FTax withholding
Common Stock
-2,967$12.70$38k64,356Mar 13, 2025
Mar 11, 2025Danilo D'Alessandro
Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-4,146--4,145Mar 13, 2025
Mar 11, 2025L. Jeremy Stigall
Chief Business Officer
MOption exercise
Restricted Stock Unitsderivative
-8,292--8,291Mar 13, 2025
Mar 6, 2025Joseph Burnett
CEO and President
MOption exercise
Common Stock
+47,407--297,283Mar 10, 2025
Mar 6, 2025L. Jeremy Stigall
Chief Business Officer
MOption exercise
Common Stock
+17,777--65,392Mar 10, 2025
Mar 6, 2025Danilo D'Alessandro
Chief Financial Officer
MOption exercise
Common Stock
+18,765--70,206Mar 10, 2025
Mar 6, 2025Mazin Sabra
Chief Operating Officer
MOption exercise
Common Stock
+13,827--51,802Mar 10, 2025
Mar 6, 2025Mazin Sabra
Chief Operating Officer
FTax withholding
Common Stock
-7,022$13.19$93k44,780Mar 10, 2025
Mar 6, 2025L. Jeremy Stigall
Chief Business Officer
FTax withholding
Common Stock
-6,361$13.19$84k59,031Mar 10, 2025
Mar 6, 2025Danilo D'Alessandro
Chief Financial Officer
FTax withholding
Common Stock
-9,529$13.19$126k60,677Mar 10, 2025
Mar 6, 2025Joseph Burnett
CEO and President
FTax withholding
Common Stock
-26,160$13.19$345k271,123Mar 10, 2025
Mar 6, 2025Mazin Sabra
Chief Operating Officer
MOption exercise
Restricted Stock Unitsderivative
-13,827--13,827Mar 10, 2025
Mar 6, 2025Joseph Burnett
CEO and President
MOption exercise
Restricted Stock Unitsderivative
-47,407--47,407Mar 10, 2025
Mar 6, 2025L. Jeremy Stigall
Chief Business Officer
MOption exercise
Restricted Stock Unitsderivative
-17,777--17,778Mar 10, 2025
Mar 6, 2025Danilo D'Alessandro
Chief Financial Officer
MOption exercise
Restricted Stock Unitsderivative
-18,765--18,765Mar 10, 2025
Mar 3, 2025Joseph Burnett
CEO and President
AGrant or award
Restricted Stock Unitsderivative
+132,841$0.00$0132,841Mar 4, 2025
Mar 3, 2025Danilo D'Alessandro
Chief Financial Officer
AGrant or award
Restricted Stock Unitsderivative
+51,660$0.00$051,660Mar 4, 2025
Mar 3, 2025L. Jeremy Stigall
Chief Business Officer
AGrant or award
Restricted Stock Unitsderivative
+44,280$0.00$044,280Mar 4, 2025
Mar 3, 2025Mazin Sabra
Chief Operating Officer
AGrant or award
Restricted Stock Unitsderivative
+33,210$0.00$033,210Mar 4, 2025
Feb 22, 2025L. Jeremy Stigall
Chief Business Officer
FTax withholding
Common Stock
-908$16.72$15k47,615Feb 25, 2025
Jan 2, 2025Pascal E R Girin
director
AGrant or award
Common Stock
+406$15.38$6,24474,493Jan 3, 2025
Jan 2, 2025R John Fletcher
director
AGrant or award
Common Stock
+375$15.38$5,76893,912Jan 3, 2025
Jan 2, 2025Timothy T. Richards
director
AGrant or award
Common Stock
+725$15.38$11k65,350Jan 3, 2025
Jan 2, 2025Linda M. Liau
director
AGrant or award
Common Stock
+193$15.38$2,96831,291Jan 3, 2025
Dec 31, 2024Joseph Burnett
CEO and President
AGrant or award
Common Stock
+251$4.53$1,137249,876Jan 3, 2025
Dec 31, 2024Danilo D'Alessandro
Chief Financial Officer
AGrant or award
Common Stock
+1,949$4.53$8,82951,441Jan 3, 2025
Dec 31, 2024Mazin Sabra
Chief Operating Officer
AGrant or award
Common Stock
+784$4.53$3,55237,975Jan 3, 2025
Dec 31, 2024L. Jeremy Stigall
Chief Business Officer
AGrant or award
Common Stock
+251$4.53$1,13748,523Jan 3, 2025
Oct 10, 2024Mazin Sabra
Chief Operating Officer
FTax withholding
Common Stock
-7,465$11.39$85k37,191Oct 11, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

CLPT insider trading: ClearPoint Neuro, Inc. | InsiderTell